Rates and effectiveness of antiviral use among hospitalized influenza patients (Q38476530)

3 September 2017

1 reference

title

Rates and effectiveness of antiviral use among hospitalized influenza patients (English)

1 reference

3 September 2017

1

Viroj Wiwanitkit

1 reference

3 September 2017

language of work or name

1 reference

12 May 2015

1 reference

Expert Review of Anti-infective Therapy

3 September 2017

published in

1 reference

3 September 2017

volume

13

1 reference

3 September 2017

issue

7

1 reference

3 September 2017

page(s)

835-842

1 reference

Influenza in animals: its possible public health significance

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Biology of influenza a virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Current research on drugs and vaccines for fighting bird flu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

How amantadine and rimantadine inhibit proton transport in the M2 protein channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Antivirals and influenza: frequency of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Antiviral treatment of influenza in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Antiviral drugs in current clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Neuraminidase inhibitor resistance in influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Current and future antiviral therapy of severe seasonal and avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

A review of neuraminidase inhibitor susceptibility in influenza strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Single‐dose inhaled laninamivir: registered in Japan and its potential role in control of influenza epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Safety and efficacy of peramivir for influenza treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Arbidol as a broad-spectrum antiviral: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

The clinical course of late diagnosed fatal cases of A (H1N1) influenza in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

The national pandemic flu service, oseltamivir, and a case of pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Prognostic factors for mortality in patients hospitalized with influenza complications, in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Optimization of antiviral prescribing for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

The clinical effectiveness of oseltamivir in mild cases of pandemic influenza A H1N1 2009 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Prediction of palmitoylation sites using the composition of k-spaced amino acid pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Emergence of drug-resistant influenza virus: population dynamical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

The safety of oseltamivir in pregnancy: an updated review of post-marketing data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of In

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.2015.1043890

10.1586/14787210.2015.1043890

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference